Kamada Ltd (KMDA) - News Archive

In a significant development for both the company and its shareholders, Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a premier player in the biopharmaceutical sector known for its expertise in specialty plasma-derived pro...

Kamada Projects Continued Profitable Growth Ahead: 2024 Financial Guidance and Ambitious Plans for 2025 Kamada Projects Continued Profitable Growth Ahead: 2024 Financial Guidance and Ambitious Plans for 2025Kamada Ltd....

Kamada Ltd., a frontrunning global biopharmaceutical firm with a robust portfolio of approved products designed to mitigate the effects of rare and serious conditions, has announced that it will publicize its financial...

In a recent letter to shareholders, Kamada Ltd., a global biopharmaceutical company based in Rehovot, Israel, and Hoboken, N.J., addressed the company s financial performance and its future outlook. Amir London, the Chi...

Kamada Ltd., a renowned global biopharmaceutical company specializing in rare and serious conditions, has recently signed a game-changing agreement with Kedrion, a key player in the field of specialty plasma-derived pro...